Colicins and microcins: the next generati... [Adv Appl Microbiol. 2004] - PubMed

loading

Review Microcins. [Biotechnology. 1995]
Review Microcins.
Moreno F, San Millán JL, Hernández-Chico C, Kolter R. Biotechnology. 1995; 28:307-21.
Escherichia coli bacteriocins: antimicrobial efficacy and prevalence among isolates from patients with bacteraemia. [PLoS One. 2011]
Escherichia coli bacteriocins: antimicrobial efficacy and prevalence among isolates from patients with bacteraemia.
Budič M, Rijavec M, Petkovšek Z, Zgur-Bertok D. PLoS One. 2011; 6(12):e28769. Epub 2011 Dec 19.
[Recombinant expression, purification and characterization of colicin S4]. [Sheng Wu Yi Xue Gong Cheng Xue...]
[Recombinant expression, purification and characterization of colicin S4].
Li X, Yang H, Wan L, Lu X. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2010 Feb; 27(1):142-6.
Review Production and release of cloacin DF13 and related colicins. [Curr Top Microbiol Immunol. 1986]
Review Production and release of cloacin DF13 and related colicins.
De Graaf FK, Oudega B. Curr Top Microbiol Immunol. 1986; 125:183-205.
Isolation and characterization of Escherichia coli strains producing microcins of B and C types. [FEMS Microbiol Lett. 1993]
Isolation and characterization of Escherichia coli strains producing microcins of B and C types.
Khmel IA, Bondarenko VM, Manokhina IM, Basyuk EI, Metlitskaya AZ, Lipasova VA, Romanova YM. FEMS Microbiol Lett. 1993 Aug 1; 111(2-3):269-74.

Proximity-dependent inhibition of growth of Mannheimia haemolytica by Pasteurella multocida. [Appl Environ Microbiol. 2012]
Proximity-dependent inhibition of growth of Mannheimia haemolytica by Pasteurella multocida.
Bavananthasivam J, Dassanayake RP, Kugadas A, Shanthalingam S, Call DR, Knowles DP, Srikumaran S. Appl Environ Microbiol. 2012 Sep; 78(18):6683-8. Epub 2012 Jul 13.
Identification and characterization of microcin S, a new antibacterial peptide produced by probiotic Escherichia coli G3/10. [PLoS One. 2012]
Identification and characterization of microcin S, a new antibacterial peptide produced by probiotic Escherichia coli G3/10.
Zschüttig A, Zimmermann K, Blom J, Goesmann A, Pöhlmann C, Gunzer F. PLoS One. 2012; 7(3):e33351. Epub 2012 Mar 30.
Escherichia coli bacteriocins: antimicrobial efficacy and prevalence among isolates from patients with bacteraemia. [PLoS One. 2011]
Escherichia coli bacteriocins: antimicrobial efficacy and prevalence among isolates from patients with bacteraemia.
Budič M, Rijavec M, Petkovšek Z, Zgur-Bertok D. PLoS One. 2011; 6(12):e28769. Epub 2011 Dec 19.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Colicins and microcins: the next generation antimicrobials.
Colicins and microcins: the next generation antimicrobials.
Adv Appl Microbiol. 2004 ;54:129-46.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed